Janssen Pharmaceuticals is pharmaceutical company established in Belgium in 1953 by Paul Janssen. Its headquarters are located in Beerse, in the Campine region of the province of Antwerp, Belgium. Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson
& Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolarI disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.
Our ultimate goal is to help people live healthy lives. We have produced and marketed many first-inclass prescription medications and are poised to serve the broad needs of the
healthcare market – from patients to practitioners, from clinics to hospitals.
Headquartered in Titusville, New Jersey, Janssen is named after Dr. Paul Janssen, a leading Belgian researcher, pharmacologist, and general practitioner. Dr. Janssen led a group of researchers to discover a medicine that helped change the way mental health patients were treated. His company, Janssen Pharmaceutica, joined the Johnson & Johnson family of companies in 1961. Our company remains guided by Dr. Janssen’s values of excellence and innovation.